Ziegler Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History

Ziegler Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$20.66 - $28.98 $342,894 - $480,981	-16,597 Reduced 49.27%	17,090 $360,000
Q4 2022 Jan 24, 2023	SELL	$20.64 - $26.24 $163,592 - $207,978	-7,926 Reduced 19.05%	33,687 $0
Q3 2022 Oct 25, 2022	SELL	$18.51 - $24.79 $4,516 - $6,048	-244 Reduced 0.58%	41,613 $1 Million
Q2 2022 Jul 21, 2022	BUY	$13.64 - $19.48 $570,929 - $815,374	41,857 New	41,857 $805,000

228

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $708M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.